CORD-19:038354e8830fe01feb621a12e8a8c467a15b6354 / 157518-157787
Annnotations
CORD-19-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T986 | 0-269 | Sentence | denotes | Currently, pharmaceutical interest in compounds with activity against respiratory viruses is limited because of a focus on chronic disease, unattractive commercial opportunities, and the high standard required to obtain FDA approval for non-life-threatening conditions. |
T26792 | 0-269 | Sentence | denotes | Currently, pharmaceutical interest in compounds with activity against respiratory viruses is limited because of a focus on chronic disease, unattractive commercial opportunities, and the high standard required to obtain FDA approval for non-life-threatening conditions. |
Epistemic_Statements
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T363 | 0-269 | Epistemic_statement | denotes | Currently, pharmaceutical interest in compounds with activity against respiratory viruses is limited because of a focus on chronic disease, unattractive commercial opportunities, and the high standard required to obtain FDA approval for non-life-threatening conditions. |
CORD-19_Custom_license_subset
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T54 | 0-269 | Sentence | denotes | Currently, pharmaceutical interest in compounds with activity against respiratory viruses is limited because of a focus on chronic disease, unattractive commercial opportunities, and the high standard required to obtain FDA approval for non-life-threatening conditions. |